May 27, 2025 / 12:30PM GMT
Christian Kanstrup - Evaxion A/S-Chief Executive Officer
Good morning and good afternoon, everyone. A very warm welcome to this Evaxon business update call on the back of our Q1 2025 results. I'm Christian Kanstrup, CEO of Evaxion. With me today, I have, as usual, Birgitte Rono, our Chief Scientific Officer; Thomas Schmidt, Chief Financial Officer; and Mads Kronborg, our VP of Investor Relations and Communications.
For the agenda today, I will do the introduction. Birgitte, she will be doing the R&D update. Thomas will take us through the numbers. And I will end up concluding before we again, as usual, will jump into the Q&A.
Before we get going, I will direct your attention to this slide. We will be talking about forward-looking statements. And as always, when you talk about the future, that is uncertain. Hence, I direct your attention to the slide here.
With that, let's get going and let's look at the introduction. I think it's fair to say that we have had a super busy couple of months since the last business update. We have seen a
Q1 2025 Evaxion A/S Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
